196 related articles for article (PubMed ID: 10515397)
1. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
2. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.
Wells AU; Lorimer S; Majumdar S; Harrison NK; Corrin B; Black CM; Jeffery PK; du Bois RM
Eur Respir J; 1995 Feb; 8(2):266-71. PubMed ID: 7758562
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.
Southcott AM; Jones KP; Li D; Majumdar S; Cambrey AD; Pantelidis P; Black CM; Laurent GJ; Davies BH; Jeffery PK
Am J Respir Crit Care Med; 1995 May; 151(5):1604-12. PubMed ID: 7735620
[TBL] [Abstract][Full Text] [Related]
4. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA).
Wallace WA; Ramage EA; Lamb D; Howie SE
Clin Exp Immunol; 1995 Sep; 101(3):436-41. PubMed ID: 7664490
[TBL] [Abstract][Full Text] [Related]
5. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
[TBL] [Abstract][Full Text] [Related]
8. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
[TBL] [Abstract][Full Text] [Related]
9. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor gene usage in patients with fibrosing alveolitis and control subjects.
Lympany PA; Southcott AM; Welsh KI; Black CM; Boylston AW; du Bois RM
Eur J Clin Invest; 1999 Feb; 29(2):173-81. PubMed ID: 10093005
[TBL] [Abstract][Full Text] [Related]
11. Interstitial vascularity in fibrosing alveolitis.
Renzoni EA; Walsh DA; Salmon M; Wells AU; Sestini P; Nicholson AG; Veeraraghavan S; Bishop AE; Romanska HM; Pantelidis P; Black CM; Du Bois RM
Am J Respir Crit Care Med; 2003 Feb; 167(3):438-43. PubMed ID: 12406847
[TBL] [Abstract][Full Text] [Related]
12. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.
Prior C; Haslam PL
Clin Exp Immunol; 1992 May; 88(2):280-7. PubMed ID: 1572093
[TBL] [Abstract][Full Text] [Related]
13. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
[TBL] [Abstract][Full Text] [Related]
15. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis.
Furuie H; Yamasaki H; Suga M; Ando M
Eur Respir J; 1997 Apr; 10(4):787-94. PubMed ID: 9150314
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.
Wallace WA; Howie SE
J Pathol; 1999 Mar; 187(4):475-80. PubMed ID: 10398109
[TBL] [Abstract][Full Text] [Related]
17. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis.
Renzoni E; Lympany P; Sestini P; Pantelidis P; Wells A; Black C; Welsh K; Bunn C; Knight C; Foley P; du Bois RM
Arthritis Rheum; 2000 Jul; 43(7):1633-40. PubMed ID: 10902769
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.
Corrin B; Butcher D; McAnulty BJ; Dubois RM; Black CM; Laurent GJ; Harrison NK
Histopathology; 1994 Feb; 24(2):145-50. PubMed ID: 8181807
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis.
Pantelidis P; Southcott AM; Black CM; Du Bois RM
Clin Exp Immunol; 1997 Apr; 108(1):95-104. PubMed ID: 9097917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]